|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash provided by (used in) Operating activities | ||
| Net loss for the year | ||
| Items not affecting cash: | ||
| Depreciation (notes 7, 19) | ||
| Amortization (note 8) | ||
| Stock-based compensation (notes 11, 12) | ||
| Accretion and other financing costs (note 9) | ||
| Interest expense (note 9) | ||
| Taxes | ||
| (Loss) gain on contingent consideration (note 4) | ||
| Gain on revaluation of options, RSUs, and derivative warrant liability (note 10,11) | ||
| Impairment of property and equipment (note 7) | ||
| Payment of taxes (note 21) | ||
| Loss on extinguishment of debt (note 9) | ||
| Other income | ||
| Foreign exchange (gain) loss (note 22) | ||
| Unrealized foreign exchange (gain) loss | ||
| Changes in non-cash operating working capital (note 14) | ||
| Cash provided by (used in) operating activities | ||
| Investing activities | ||
| Purchase of property and equipment (note 7) | ||
| Business acquisitions (note 4) | ||
| Earn out payment (note 4) | ||
| Development costs related to internally generated intangible assets (note 8) | ||
| Change in restricted cash | ||
| Cash used in investing activities | ||
| Financing activities | ||
| Issuance of share capital, net of issuance costs (notes 10, 11) | ||
| Issuance cost reimbursement | ||
| Proceeds from exercise of stock options (note 11) | ||
| Proceeds from exercise of warrants (note 11) | ||
| Payment of amendment fees on debt (note 9) | ||
| Repayment of debt (note 9) | ||
| Repayment of lease obligations (note 20) | ||
| Payment of interest on debt (note 9) | ||
| Payment of interest on lease obligations (note 20) | ||
| Cash provided by (used in) financing activities | ||
| Net increase (decrease) in cash for the year | ||
| Cash, beginning of year | ||
| Effect of exchange rate changes on cash | ||
| Cash, end of year |
Loading...
